Mrv0541 02231217292D 10 9 0 0 0 0 999 V2000 1.7605 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4750 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1895 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9039 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6184 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.3329 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.0474 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9039 0.6039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6184 0.1914 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.1895 0.1914 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 4 8 1 0 0 0 0 8 9 1 0 0 0 0 8 10 2 0 0 0 0 M END > DB04165 > drugbank > CCCC(CCC)C(N)=O > InChI=1S/C8H17NO/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H2,9,10) > OMOMUFTZPTXCHP-UHFFFAOYSA-N > C8H17NO > 143.2267 > 143.131014171 > 1 > 27 > 8.72053853531506e-09 > 17.369505797110307 > 1 > 1 > 0 > 0 > 2-propylpentanamide > 2.38 > 1.9915084573333333 > -1.61 > 0 > 0 > 0 > 0 > 17.092385388023676 > -1.0554494037662265 > 43.09 > 42.07130000000001 > 5 > 1 > 3.52e+00 g/l > tetrahydrofolic acid > 0 > DB04165 > EXPT03231 > experimental > Valpromide > Valpromida; Valpromide $$$$